Bright Minds Biosciences (DRUG) Stock Chart & Stock Price History $43.96 +3.14 (+7.69%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$42.58 -1.38 (-3.14%) As of 02/7/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Bright Minds Biosciences Stock Price Performance 5 Day Performance+14.24%1 Month Performance+13.04%3 Month Performance-5.71%6 Month Performance+3,842.60%Year-To-Date Performance+22.04%1 Year Performance+2,201.57% Receive DRUG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address DRUG Stock Chart for Monday, February, 10, 2025 DRUG Chart by TradingView Bright Minds Biosciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/07/2025$40.82$43.96+7.69%$44.47$39.3483,583 shs$194.74 million02/06/2025$38.48$40.82+6.08%$41.34$37.7590,347 shs$180.83 million02/05/2025$37.65$38.48+2.20%$38.50$37.0074,342 shs$170.47 million02/04/2025$37.25$37.65+1.07%$37.86$36.1558,528 shs$166.79 million02/03/2025$34.00$37.25+9.56%$37.50$32.51104,681 shs$165.02 million01/31/2025$32.39$34.00+4.97%$34.12$32.4858,644 shs$150.62 million01/30/2025$29.86$32.39+8.47%$32.44$29.7544,683 shs$143.49 million01/29/2025$30.30$29.86-1.45%$30.97$29.1146,521 shs$132.28 million01/28/2025$30.03$30.30+0.90%$30.73$28.2170,772 shs$134.23 million01/27/2025$32.09$30.03-6.42%$32.75$28.7179,135 shs$142.28 million Get the Latest News and Ratings for DRUG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. 01/24/2025$32.28$32.09-0.59%$34.55$31.00113,145 shs$142.16 million01/23/2025$33.35$32.28-3.21%$35.00$30.72366,519 shs$143 million01/22/2025$35.49$33.35-6.03%$36.91$32.2596,793 shs$147.74 million01/21/2025$36.78$35.49-3.51%$37.29$35.1244,647 shs$157.22 million01/20/2025$36.78$36.78$37.36$35.9382,339 shs$162.94 million01/17/2025$36.60$36.78+0.49%$37.36$35.9382,339 shs$162.94 million01/16/2025$35.92$36.60+1.89%$38.00$36.3085,512 shs$162.14 million01/15/2025$35.24$35.92+1.93%$38.00$35.16146,871 shs$159.27 million01/14/2025$35.41$35.24-0.48%$36.59$35.0299,027 shs$156.25 million01/13/2025$38.89$35.41-8.95%$38.38$35.4199,473 shs$157.01 million01/10/2025$41.04$38.89-5.24%$41.99$38.2448,725 shs$172.44 million01/09/2025$41.04$41.04$41.04$38.4934,563 shs$181.97 million Related Companies Dianthus Therapeutics Stock Chart Immunome Stock Chart Kura Oncology Stock Chart Verve Therapeutics Stock Chart Immatics Stock Chart Arbutus Biopharma Stock Chart Stoke Therapeutics Stock Chart Rapport Therapeutics Stock Chart CorMedix Stock Chart Cullinan Therapeutics Stock Chart Receive DRUG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRUG) was last updated on 2/10/2025 by MarketBeat.com Staff From Our PartnersBig Tech’s $17 Trillion Reckoning DayThe world's biggest tech companies are silently sounding the alarm. While everyday investors keep piling in...InvestorPlace | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTop 5 Trump Stocks for His First 100 DaysRight now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon’s ‘Agents’ StrikeHe might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...Altimetry | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.